News

Podcast

February 24, 2019

Podcast: This Week in Managed Care—CAR T Therapy Coverage and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care^® (AJMC^®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included CMS' proposal to cover chimeric antigen receptor T-cell therapy; a study faulting the FDA’s handling of fentanyl oversight; and breast surgeons calling for genetic testing for all patients with breast cancer.

You may need to log in to the website to access this podcast.

Listen above or through one of these podcast services:

Read more about the stories in this podcast:

CMS Proposes That Patients Be Enrolled in Studies to Get Coverage for CAR T-Cell Therapy

Study Criticizes FDA Safety Oversight of Rapid-Release Fentanyl

Breast Surgeons Seek Genetic Testing for All Patients With Breast Cancer

Greater Diet Drink Consumption Heightens Stroke Risk in Postmenopausal Women

Related Videos

Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center

Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth

Cathy Eng, MD, FACP, FASCO

Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC

Screenshot of an interview with Shaun McKenzie, MD

Screenshot of an interview with Shaun McKenzie, MD

Screenshot of an interview with Rohan Garje, MD

Susan Escudier, MD, FACP

Sabarish Ayyappan, MD

Related Content

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com

April 29th 2025

New Developments Warrant Rethinking HCC Transplant Criteria

Jared Kaltwasser

Downstaging and bridging strategies are changing how hepatocellular carcinoma (HCC) is treated.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

senior scientist | Image credit: Ohio State University

April 28th 2025

Proving the Concept: A Sampler of Early-Stage Science at AACR 2025

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ground.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com

April 23rd 2025

Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

AJMC Contributor

Even with prevention measures and timely, aggressive intervention, tumor lysis syndrome (TLS) remains life-threatening, as a case study in small cell lung cancer (SCLC) illustrates.

Diabetes monitoring | Image credit: abidika - stock.adobe.com

April 23rd 2025

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 diabetes—but not all obesity-related cancers show a link.

Related Content

The thinking around which patients are eligible for liver transplants needs to evolve, the authors noted, as the criteria used to evaluate fitness for transplant were proposed nearly three decades ago. | Image credit: Peakstock - stock.adobe.com

April 29th 2025

New Developments Warrant Rethinking HCC Transplant Criteria

Jared Kaltwasser

Downstaging and bridging strategies are changing how hepatocellular carcinoma (HCC) is treated.

April 22nd 2025

New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix

Brooke McCormick Brady Post, PhD

On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.

senior scientist | Image credit: Ohio State University

April 28th 2025

Proving the Concept: A Sampler of Early-Stage Science at AACR 2025

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ground.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

Considering the life-threatening risk of TLS, the researchers underscored the importance of identifying patients at particular risk of the complication. | Image credit: mi_viri - stock.adobe.com

April 23rd 2025

Optimized Strategies Needed for TLS Prevention, Intervention in SCLC

AJMC Contributor

Even with prevention measures and timely, aggressive intervention, tumor lysis syndrome (TLS) remains life-threatening, as a case study in small cell lung cancer (SCLC) illustrates.

Diabetes monitoring | Image credit: abidika - stock.adobe.com

April 23rd 2025

New-Onset Type 2 Diabetes Linked to Higher Cancer Risk

A new study has found increased risks for liver, pancreatic, and bowel cancers following a new diagnosis of type 2 diabetes—but not all obesity-related cancers show a link.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions